HCPCS code J9334 — Inj efgart-alfa 2mg hya-qvfc.
Status: Active.
Effective Jan 1, 2024.
Source: CMS HCPCS Level II.
J9334
ActiveInj efgart-alfa 2mg hya-qvfc
Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2024
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
0723
MUE — Medically Unlikely Edits
Maximum units of J9334 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 504 |
| Practitioner Services | 504 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 73475-1221-01 | Vyvgart Hytrulo |
| 73475-1221-04 | Vyvgart Hytrulo |
| 73475-3102-03 | Vyvgart Hytrulo |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q1Inj efgart-alfa 2mg hya-qvfc